Verition Fund Management
ACHV icon

Verition Fund Management’s Achieve Life Sciences ACHV Stock Holding History

Verition Fund Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,805
Closed -$113K – 3208
2024
Q3 		$113K Buy
+23,805
New +$109K ﹤0.01% 2982
2014
Q3 		– Sell
-6
Closed -$47K – 696
2014
Q2 		$47K Buy
+6
New +$73.7K 0.01% 634

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management's ACHV Position: Q4 2024 in Review

Verition Fund Management sold out of Achieve Life Sciences (ACHV) in Q4 2024, closing a stake of 23,805 shares — an estimated $113K sold.

Verition Fund Management first reported a position in ACHV in Q2 2014 and held it in 2 quarters. The position peaked at $113K in Q3 2024. 70 funds tracked by Wall St. Rank hold ACHV as of Q4 2024.

  • Verition Fund Management reported no remaining Achieve Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 23,805 Achieve Life Sciences shares in Q4 2024, an estimated $113K.
  • Verition Fund Management first reported a position in Achieve Life Sciences in Q2 2014 and held it in 2 quarters.
  • Verition Fund Management's Achieve Life Sciences position peaked at $113K in Q3 2024.
  • 70 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.